Ribomic Balance Sheet Health
Financial Health criteria checks 6/6
Ribomic has a total shareholder equity of ¥3.3B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥3.4B and ¥109.0M respectively.
Key information
0%
Debt to equity ratio
JP¥0
Debt
| Interest coverage ratio | n/a |
| Cash | JP¥3.26b |
| Equity | JP¥3.29b |
| Total liabilities | JP¥109.00m |
| Total assets | JP¥3.39b |
Financial Position Analysis
Short Term Liabilities: 4591's short term assets (¥3.4B) exceed its short term liabilities (¥108.0M).
Long Term Liabilities: 4591's short term assets (¥3.4B) exceed its long term liabilities (¥1,000.0K).
Debt to Equity History and Analysis
Debt Level: 4591 is debt free.
Reducing Debt: 4591 has no debt compared to 5 years ago when its debt to equity ratio was 9.4%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4591 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 4591 has sufficient cash runway for 2.7 years if free cash flow continues to reduce at historical rates of 7.6% each year.